Effect of Mycobacterium tuberculosis higBA on Bacterial Stress Response and Intracellular Infection and Immunity

WANG Xin-ya , LUO Tao, CHEN Zong-hai, LIAO Wei, WANG Yi, BAO Lang

Abstract

To investigate the effect of Mycobacterium tuberculosis (Mtb) higBA on bacterial stress response and intracellular infection and immunity.  Methods  The target gene amplified from Mtb H37Rv genome was cloned to the vector and then transferred to Mycobacterium smegmatis (Ms) to construct a recombinant strain. Stress response experiment and Raw264.7 mouse macrophage infection was carried out with Ms_higBA, the recombinant strain, and Ms_ vec, the vector strain. Tests were conducted to measure bacterial colony forming unit (CFU) and transcriptional levels of cytokines, including interleukin (IL)-1β, IL-6, IL-10, IL-12p40, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and inducible nitric oxide synthase (iNOS).  Results  The recombinant strain, Ms_higBA, was constructed successfully. According to the findings of the stress response experiment, higBA could indeed enhance bacterial survival under certain conditions of in vitro culture. Intracellular infection experiment demonstrated that higBA enhanced bacterial survival in macrophages and influenced the transcriptional level of cytokines.  Conclusion  The higBA genes from Mtb play a role in bacterial stress response and intracellular infection and immunity.

 

Keywords: Mycobacterium tuberculosis, higBA, Stress response, Intracellular infection and immunity

 

Full Text:

PDF


References


World Health Organization. WHO global tuberculosis report 2020.(2021-10-14)[2021-11-03]. https://www.who.int/publications/i/item/ 9789240037021/14Oct2021.

SULTAN I， RAHMAN S， JAN A T， et al. Antibiotics， resistome and resistance mechanisms: A bacterial perspective. Front Microbiol， 2018， 9: 2066−2082[2021-11-03]. https://www.frontiersin.org/articles/10.3389/fmicb.2018.02066/full/. doi: 10.3389/fmicb.2018.02066.

ZAYCHIKOVA M V， ZAKHAREVICH N V， SAGAIDAK M O， et al. Mycobacterium tuberculosis type Ⅱ toxin-antitoxin systems: Genetic polymorphisms and functional properties and the possibility of their use for genotyping. PLoS One， 2015， 10(12): e0143682[2021-11-03]. https://pubmed.ncbi.nlm.nih.gov/26658274/. doi: 10.1371/journal.pone.0143682.

TRASTOY R， MANSO T， FERNÁNDEZ-GARCÍA L， et al. Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments. Clin Microbiol Rev， 2018， 31(4): e00023−18[2021-11-03]. https://pubmed.ncbi.nlm.nih.gov/30068737/. doi: 10.1128/CMR.00023-18.

KANG S M， KIM D H， JIN C， et al. A systematic overview of type Ⅱ and Ⅲ toxin-antitoxin systems with a focus on druggability. Toxins (Basel)，2018，10(12): 515–536.

TANDON H， SHARMA A， SANDHYA S， et al. Mycobacterium tuberculosis Rv0366c-Rv0367c encodes a non-canonical PezAT-like toxin-antitoxin pair. Sci Rep，2019，9(1): 1163–1177.

GUPTA A， VENKATARAMAN B， VASUDEVAN M， et al. Co-expression network analysis of toxin-antitoxin loci in Mycobacterium tuberculosis reveals key modulators of cellular stress. Sci Rep，2017，7(1): 5868–5882.

ABIGAIL S， ALAINE R， ANDREWS E S V， et al. VapC proteins from Mycobacterium tuberculosis share ribonuclease sequence specificity but differ in regulation and toxicity. PLoS One， 2018， 13(8): e0203412[2021-11-03]. https://pubmed.ncbi.nlm.nih.gov/30169502/. doi: 10.1371/journal. pone.0203412.

DE WELZEN L， ELDHOLM V， MAHARAJ K， et al. Whole-transcriptome and -genome analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance. Antimicrob Agents Chemother， 2017， 61(12): e01461−17[2021-11-03]. https://pubmed.ncbi. nlm.nih.gov/28993337/. doi: 10.1128/AAC.01461-17.

LUNGE A， GUPTA R， CHOUDHARY E， et al. The unfoldase ClpC1 of Mycobacterium tuberculosis regulates the expression of a distinct subset of proteins having intrinsically disordered termini. J Biol Chem， 2020， 295: 9455−9473[2021-11-03]. https://linkinghub.elsevier.com/retrieve/pii/S0021-9258(17)48966-6/. doi: 10.1074/jbc.RA120.013456.

WANG X Y， ZHAO X K， WANG H， et al. Mycobacterium tuberculosis toxin Rv2872 is an RNase involved in vancomycin stress response and biofilm development. Appl Microbiol Biot，2018，102(16): 7123–7133.

YAMADA Y， DICK T. Mycobacterial caseinolytic protease gene regulator ClgR is a substrate of caseinolytic protease. mSphere， 2017， 2(2): e00338−16[2021-11-03]. https://pubmed.ncbi.nlm.nih.gov/ 28317028/. doi: 10.1128/mSphere.00338-16.

CULVINER P H， LAUB M T. Global analysis of the E.coli toxin MazF reveals widespread cleavage of mRNA and the inhibition of rRNA maturation and ribosome biogenesis. Mol Cell，2018，70(5): 868–880. BARTH V C， ZENG J M， VVEDENSKAYA I O， et al. Toxin-mediated ribosome stalling reprograms the Mycobacterium tuberculosis proteome. Nat Commun，2019，10(1): 3035–3045.

PROZOROV A A， FEDOROVA I A， BEKKER O B， et al. The virulence factors of Mycobacterium tuberculosis: Genetic control, new conceptions. Genetika，2014，50(8): 885–908.

TIWARI P， ARORA G， SINGH M， et al. MazF ribonucleases promote Mycobacterium tuberculosis drug tolerance and virulence in guinea pigs. Nat Commun， 2015， 6: 6059−6072[2021-11-03]. https://www.nature. com/articles/ncomms7059/. doi: 10.1038/ncomms7059.

O'GARRA A， REDFORD P S， MCNAB F W， et al. The immune response in tuberculosis. Annu Rev Immunol， 2013， 31: 475−527[2021-11-03]. https://arjournals.annualreviews.org/doi/10.1146/annurev-immunol-032712-095939?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_ dat=cr_pub%20%200pubmed/. doi: 10.1146/annurev-immunol-032712–095939.

KATHAMUTHU G R， MOIDEEN K， BHASKARAN D， et al. Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis. Cytokine，2017，90(Complete): 66–72.

ZAMBUZI F A， CARDOSO-SILVA P M， ESPINDOLA M S， et al. Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis. Cytokine， 2016， 88: 99−107[2021-11-03]. https://linkinghub.elsevier.com/retrieve/pii/S1043-4666(16)30484-7/. doi: 10.1016/j.cyto.2016.08.030.

LEE I G， LEE S J， CHAE S， et al. Structural and functional studies of the Mycobacterium tuberculosis VapBC30 toxin-antitoxin system: Implications for the design of novel antimicrobial peptides. Nucleic Acids Res，2015，43(15): 7624–7637.


Refbacks

  • There are currently no refbacks.